Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Capital Expenditures: 2023

Historic Capital Expenditures for ADC Therapeutics (ADCT) over the last 1 years, with Dec 2023 value amounting to $327,000.

  • ADC Therapeutics' Capital Expenditures was N/A to $327,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $867,000 for FY2024, which is 73.04% down from last year.
  • ADC Therapeutics' Capital Expenditures amounted to $327,000 in Q4 2023, which was down 50.53% from $661,000 recorded in Q3 2023.
  • ADC Therapeutics' Capital Expenditures' 5-year high stood at $1.2 million during Q2 2023, with a 5-year trough of $327,000 in Q4 2023.
  • Over the past 1 years, ADC Therapeutics' median Capital Expenditures value was $838,500 (recorded in 2023), while the average stood at $804,000.